首頁 › 慢性骨髓性白血病 › 華盛頓州 › Seattle
Seattle, WA 的 慢性骨髓性白血病 臨床試驗
11 項針對 慢性骨髓性白血病 的研究正在 Seattle（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- 還有 1 項
Study of Olverembatinib (HQP1351) in Patients With CML-CP
招募中3 期
- Ascentage Investigative Site #1806, Seattle
- Ascentage Investigative Site #1510, Seattle
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
招募中2 期
- Seattle Childrens Hospital, Seattle
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
招募中2 期
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中觀察性研究
- Fred Hutchinson Cancer Research Center, Seattle
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
招募中2 期歡迎健康志工
- Fred Hutch/University of Washington Cancer Consortium, Seattle
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
招募中1 期
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
招募中2 期
- Fred Hutchinson Cancer Center, Seattle
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
招募中1/2 期
- Fred Hutchinson Cancer Center, Seattle
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
招募中1 期
- Fred Hutchinson Cancer Research Center, Seattle
TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia
招募中1 期
- Fred Hutchinson Cancer Center, Seattle
其他城市的 慢性骨髓性白血病 試驗
- Houston, TX18 項研究
- New York City, NY11 項研究
- Birmingham, AL6 項研究
- Detroit, MI6 項研究
- Chicago, IL6 項研究
- Portland, OR6 項研究
- Philadelphia, PA6 項研究
- Baldwin Park, CA6 項研究
- Nashville, TN5 項研究
- Columbus, OH5 項研究
- Boston, MA5 項研究
- Atlanta, GA5 項研究
Seattle 的其他研究
- 非小細胞肺癌53 項研究
- 癌症（所有類型）49 項研究
- 前列腺癌42 項研究
- 急性髓系白血病40 項研究
- 乳癌39 項研究
- 轉移性癌症39 項研究
- 大腸直腸癌34 項研究
- 肺癌33 項研究
- 卵巢癌30 項研究
- 多發性骨髓瘤22 項研究
- 骨髓增生異常症候群21 項研究
- 急性淋巴母細胞性白血病21 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。